Affordable Access

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

Authors
Type
Published Article
Journal
Journal of the American Academy of Child & Adolescent Psychiatry
0890-8567
Publisher
Elsevier
Publication Date
Volume
42
Issue
6
Pages
673–683
Identifiers
PMID: 12921475
Source
Medline
License
Unknown

Abstract

These data provide support for the benefit of this novel, once-daily amphetamine preparation in the treatment of ADHD. The longer duration of action of SLI381 has the potential to simplify psychostimulant dosing, thus reducing dose diversion and eliminating the need for in-school administration. SLI381 appears to be a useful treatment option for many children with ADHD.

Statistics

Seen <100 times